Date
HS Code
Importer
Exporter
Product Description
Country of Origin
Destination Country
Port of Loading
Port of Discharge
Weight
(unit)
Quantity
(unit)
Value
(unit)
2020-09-11
PHARMACEUTICALS - 1 X 40 HR FCL TOTAL 31 PA LLETS CONTAINS 1143 CARTON S PHARMACEUTICALS [46699 X 1X100S] MAR -ALLOPURINOL 100MG [ALLOPURINOL TABLETS USP 100MG] DIN NO.: 02396 327, UPC CODE.: 6973590009 82, PO NO.: 3200001820, [3 511 X 1X1000S] MAR -ALLOP
PHARMACEUTICALS - 1 X 40 HR FCL TOTAL 31 PA LLETS CONTAINS 1143 CARTON S PHARMACEUTICALS [46699 X 1X100S] MAR -ALLOPURINOL 100MG [ALLOPURINOL TABLETS USP 100MG] DIN NO.: 02396 327, UPC CODE.: 6973590009 82, PO NO.: 3200001820, [3 511 X 1X1000S] MAR -ALLOP
47094, VALENCIA
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
8,262
KG
31
PKG
4,626,944
USD
2021-07-07
POTASSIUM CHLORIDE SR TABLETS 600 MG - CONTAINING [TOTAL ONE THOU SAND FOUR HUNDRED NINETYO NE PACKAGES ONLY] TOTAL 49 PLTS CONTAINING 1491 PKGS POTASSIUM CHLORIDE SR TAB LETS 600 MG [OTHER DETAILS AS PER INVOICE] [651 PKGS ] POTASSIUM CHLORIDE SR TA BLETS 1500 MG [OTHER DETAI LS AS PER INVOICE] [840 PK GS] HS CO DE: 30042019 TEMP : 18 DEG CEL. VENTILATION: CLOSE HUMIDITY: YES, 60 P ER CENT INV NO: SRIE210002 DT: 27.04.2021, S.BILL NO:1526739 D T:03.05.2021, NET.WT: 6846.000 KGS, GR. WT:7353.760, [21 PLT ] I NV NO:SRIE210003 DT: 27 .04 .2021, S.BILL NO:1526730 D T: 03.05.2021,NET.WT: 112 69.550 KGS, GR.WT: 11911.7 30, [ 28 PLT ] FUMIGATI ON CERTIFICATE NO: EXP /33 /2021-22/3067 DT:13.05.202 1 FUMIGATION CERTIFICATE NO: EXP/33/2021-22/2976 DT :12.05.2021 THE TEMPERATUR E SET AT PLUS 18 DEGREES C ELCIUS IN ACCORDANCE WITH SHIPPER S INSTRUCTIONS FUM IGATION CERTIFICATE NO.EXP /33/2021-22/3067 DATED 13/ 05/2021
POTASSIUM CHLORIDE SR TABLETS 600 MG - CONTAINING [TOTAL ONE THOU SAND FOUR HUNDRED NINETYO NE PACKAGES ONLY] TOTAL 49 PLTS CONTAINING 1491 PKGS POTASSIUM CHLORIDE SR TAB LETS 600 MG [OTHER DETAILS AS PER INVOICE] [651 PKGS ] POTASSIUM CHLORIDE SR TA BLETS 1500 MG [OTHER DETAI LS AS PER INVOICE] [840 PK GS] HS CO DE: 30042019 TEMP : 18 DEG CEL. VENTILATION: CLOSE HUMIDITY: YES, 60 P ER CENT INV NO: SRIE210002 DT: 27.04.2021, S.BILL NO:1526739 D T:03.05.2021, NET.WT: 6846.000 KGS, GR. WT:7353.760, [21 PLT ] I NV NO:SRIE210003 DT: 27 .04 .2021, S.BILL NO:1526730 D T: 03.05.2021,NET.WT: 112 69.550 KGS, GR.WT: 11911.7 30, [ 28 PLT ] FUMIGATI ON CERTIFICATE NO: EXP /33 /2021-22/3067 DT:13.05.202 1 FUMIGATION CERTIFICATE NO: EXP/33/2021-22/2976 DT :12.05.2021 THE TEMPERATUR E SET AT PLUS 18 DEGREES C ELCIUS IN ACCORDANCE WITH SHIPPER S INSTRUCTIONS FUM IGATION CERTIFICATE NO.EXP /33/2021-22/3067 DATED 13/ 05/2021
POTASSIUM CHLORIDE SR TABLETS 600 MG - CONTAINING [TOTAL ONE THOU SAND FOUR HUNDRED NINETYO NE PACKAGES ONLY] TOTAL 49 PLTS CONTAINING 1491 PKGS POTASSIUM CHLORIDE SR TAB LETS 600 MG [OTHER DETAILS AS PER INVOICE] [651 PKGS ] POTASSIUM CHLORIDE SR TA BLETS 1500 MG [OTHER DETAI LS AS PER INVOICE] [840 PK GS] HS CO DE: 30042019 TEMP : 18 DEG CEL. VENTILATION: CLOSE HUMIDITY: YES, 60 P ER CENT INV NO: SRIE210002 DT: 27.04.2021, S.BILL NO:1526739 D T:03.05.2021, NET.WT: 6846.000 KGS, GR. WT:7353.760, [21 PLT ] I NV NO:SRIE210003 DT: 27 .04 .2021, S.BILL NO:1526730 D T: 03.05.2021,NET.WT: 112 69.550 KGS, GR.WT: 11911.7 30, [ 28 PLT ] FUMIGATI ON CERTIFICATE NO: EXP /33 /2021-22/3067 DT:13.05.202 1 FUMIGATION CERTIFICATE NO: EXP/33/2021-22/2976 DT :12.05.2021 THE TEMPERATUR E SET AT PLUS 18 DEGREES C ELCIUS IN ACCORDANCE WITH SHIPPER S INSTRUCTIONS FUM IGATION CERTIFICATE NO.EXP /33/2021-22/3067 DATED 13/ 05/2021
POTASSIUM CHLORIDE SR TABLETS 600 MG - CONTAINING [TOTAL ONE THOU SAND FOUR HUNDRED NINETYO NE PACKAGES ONLY] TOTAL 49 PLTS CONTAINING 1491 PKGS POTASSIUM CHLORIDE SR TAB LETS 600 MG [OTHER DETAILS AS PER INVOICE] [651 PKGS ] POTASSIUM CHLORIDE SR TA BLETS 1500 MG [OTHER DETAI LS AS PER INVOICE] [840 PK GS] HS CO DE: 30042019 TEMP : 18 DEG CEL. VENTILATION: CLOSE HUMIDITY: YES, 60 P ER CENT INV NO: SRIE210002 DT: 27.04.2021, S.BILL NO:1526739 D T:03.05.2021, NET.WT: 6846.000 KGS, GR. WT:7353.760, [21 PLT ] I NV NO:SRIE210003 DT: 27 .04 .2021, S.BILL NO:1526730 D T: 03.05.2021,NET.WT: 112 69.550 KGS, GR.WT: 11911.7 30, [ 28 PLT ] FUMIGATI ON CERTIFICATE NO: EXP /33 /2021-22/3067 DT:13.05.202 1 FUMIGATION CERTIFICATE NO: EXP/33/2021-22/2976 DT :12.05.2021 THE TEMPERATUR E SET AT PLUS 18 DEGREES C ELCIUS IN ACCORDANCE WITH SHIPPER S INSTRUCTIONS FUM IGATION CERTIFICATE NO.EXP /33/2021-22/3067 DATED 13/ 05/2021
47094, VALENCIA
1001, NEW YORK, NY
19,265
KG
1,491
PKG
8,091,489
USD
2020-09-11
PHARMACEUTICALS - TOTAL 32 PALLETS CONTAINS 592 CARTONS PHARMACEUTICAL S [10270 X 1X100S] JAMP-RI SPERIDONE 1.0MG [RISPERIDO NE TABLETS1MG] DIN NO.: 0 2359545 , UPC CODE.: 62208 2 286556 , PO NO.: 32000018 10 [6274 X 1X100S] JAMP-RI SPERIDONE 2.0MG [RISPE
PHARMACEUTICALS - TOTAL 32 PALLETS CONTAINS 592 CARTONS PHARMACEUTICAL S [10270 X 1X100S] JAMP-RI SPERIDONE 1.0MG [RISPERIDO NE TABLETS1MG] DIN NO.: 0 2359545 , UPC CODE.: 62208 2 286556 , PO NO.: 32000018 10 [6274 X 1X100S] JAMP-RI SPERIDONE 2.0MG [RISPE
47094, VALENCIA
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
3,288
KG
32
PKG
4,275,570
USD
2020-04-07
01X40HC REEFER WITH1537 BOXES ON 20 PALLETS CONTAINING: CEFTAZIDIME 2GR 10SPREMIER (108689C) CEFTAZIDIME 1GR 25SSAGENT (108705C) CEFTAZIDIME 1GR 25SSAGENT (108706C) COMMERCIAL INVOICE:ABL 003804, ABL 003805 NET WEIGHT: 305,826KGS RUC: 0BR05439635200000000
01X40HC REEFER WITH1537 BOXES ON 20 PALLETS CONTAINING: CEFTAZIDIME 2GR 10SPREMIER (108689C) CEFTAZIDIME 1GR 25SSAGENT (108705C) CEFTAZIDIME 1GR 25SSAGENT (108706C) COMMERCIAL INVOICE:ABL 003804, ABL 003805 NET WEIGHT: 305,826KGS RUC: 0BR05439635200000000
35177, SAO PAULO
1601, CHARLESTON, SC
8,307
KG
1,537
BOX
166,140
USD
2020-10-19
10 PALLETS 581 CARTONS PHA RMACEUTICALS AS UNDER POTA SSIUM CL ER CAPS 10MEQ (75 0MG) 500 S NDC CODE:684620 35705 FDA PRODUCT CODE NO. : 65 R C F 14 H. T. S NO.: 3004.90.92.90 ANDANO.: 2 02868 THERAPEUTICE USE: - TREATMENT O R PREVENTION OF HYPOKALEMIA PO
10 PALLETS 581 CARTONS PHA RMACEUTICALS AS UNDER POTA SSIUM CL ER CAPS 10MEQ (75 0MG) 500 S NDC CODE:684620 35705 FDA PRODUCT CODE NO. : 65 R C F 14 H. T. S NO.: 3004.90.92.90 ANDANO.: 2 02868 THERAPEUTICE USE: - TREATMENT O R PREVENTION OF HYPOKALEMIA PO
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
2,130
KG
10
PKG
***
USD
2021-11-18
1X 40 REEFER FCL 41 PALLETS CONSISTING OF 3143 CARTONS PH ARMACEUTICALS AS UNDER TELMIS ARTAN TABLETS 20MG 30 S NDC C ODE:68462019930 FDA PRODUCT C ODE NO.: 62 O C A 09 H. T. S NO.: 3004.90.92.20 ANDA NO. :090032 THERAPEUTICE USE: IN DICATED FOR THE TREATMENT OF HYPERTENSION, TO LOWER BLOOD PRESSURE NAPROXEN TABLETS 50 0MG 500 S NDC CODE:6846201900 5 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90 .92.40 ANDA NO.:-78-250 THER APEUTICE USE:-ANTI-INFLAMMATO RY, ANALGESIC INDOMETHACIN C APS 25MG 100 S NDC CODE:68462 040601 FDA PRODUCT CODE NO.: 62 G C E 42 H. T. S NO.: 30 04.90.92.40 ANDA NO.:91-276 THERAPEUTICE USE: ANTI-INFLAM ATORY ROPINIROLE TABS 0.5MG 1 00 S NDC CODE:68462025401 FD A PRODUCT CODE NO.:-62 J C A 17 H. T. S NO.: 3004.90.92.4 0 ANDA NO.:- 90-135 THERAPEU TICE USE:-TREATMENT OF PARKI NSONISM OXCARBAZEPINE TABLETS 300MG 100 S NDC CODE:684620 13801 FDA PRODUCT CODE NO. :-61 M C A 45 H. T. S NO.: 3004.90.92.30 ANDA NO.:-77- 802 THERAPEUTICE USE:-ANTI CONVULSANT AGENT LITHIUM CA RBONATE CAPS 150MG 100 S NDC CODE:68462022001 FDA PRODUC T CODE NO.:-61 N C E 37 H. T. S NO.: 3004.49.00.20 A NDA NO.:- 79 -139 THERAPEUTI CE USE:-ANTIMANIC AGENT LA MOTRIGINE TABLETS FOR OS(CD)25 MG100 S NDC CODE:68462022901 FDA PRODUCT CODE NO.:-61 M C A 38 H. T. S NO.: 3004.90. 92.30 ANDA NO.:-79 # 099 T HERAPEUTICE USE:-ANTICONVULSAN T 02 DATA LOGGERS SET T EMPERATURE : +20 DEGREES TEM PERATURE RANGE : +15 DEGREES T O +25 DEGREES COMMERCIAL & C USTOM INVOICE NO. F2225200379 1 DT. 22.10.2021 SBILL NO DT 5495765 23.10.20 21 TOTAL GR.WT.:10911.61KGS TOTAL NT.WT.:8849.48KGS
1X 40 REEFER FCL 41 PALLETS CONSISTING OF 3143 CARTONS PH ARMACEUTICALS AS UNDER TELMIS ARTAN TABLETS 20MG 30 S NDC C ODE:68462019930 FDA PRODUCT C ODE NO.: 62 O C A 09 H. T. S NO.: 3004.90.92.20 ANDA NO. :090032 THERAPEUTICE USE: IN DICATED FOR THE TREATMENT OF HYPERTENSION, TO LOWER BLOOD PRESSURE NAPROXEN TABLETS 50 0MG 500 S NDC CODE:6846201900 5 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90 .92.40 ANDA NO.:-78-250 THER APEUTICE USE:-ANTI-INFLAMMATO RY, ANALGESIC INDOMETHACIN C APS 25MG 100 S NDC CODE:68462 040601 FDA PRODUCT CODE NO.: 62 G C E 42 H. T. S NO.: 30 04.90.92.40 ANDA NO.:91-276 THERAPEUTICE USE: ANTI-INFLAM ATORY ROPINIROLE TABS 0.5MG 1 00 S NDC CODE:68462025401 FD A PRODUCT CODE NO.:-62 J C A 17 H. T. S NO.: 3004.90.92.4 0 ANDA NO.:- 90-135 THERAPEU TICE USE:-TREATMENT OF PARKI NSONISM OXCARBAZEPINE TABLETS 300MG 100 S NDC CODE:684620 13801 FDA PRODUCT CODE NO. :-61 M C A 45 H. T. S NO.: 3004.90.92.30 ANDA NO.:-77- 802 THERAPEUTICE USE:-ANTI CONVULSANT AGENT LITHIUM CA RBONATE CAPS 150MG 100 S NDC CODE:68462022001 FDA PRODUC T CODE NO.:-61 N C E 37 H. T. S NO.: 3004.49.00.20 A NDA NO.:- 79 -139 THERAPEUTI CE USE:-ANTIMANIC AGENT LA MOTRIGINE TABLETS FOR OS(CD)25 MG100 S NDC CODE:68462022901 FDA PRODUCT CODE NO.:-61 M C A 38 H. T. S NO.: 3004.90. 92.30 ANDA NO.:-79 # 099 T HERAPEUTICE USE:-ANTICONVULSAN T 02 DATA LOGGERS SET T EMPERATURE : +20 DEGREES TEM PERATURE RANGE : +15 DEGREES T O +25 DEGREES COMMERCIAL & C USTOM INVOICE NO. F2225200379 1 DT. 22.10.2021 SBILL NO DT 5495765 23.10.20 21 TOTAL GR.WT.:10911.61KGS TOTAL NT.WT.:8849.48KGS
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
10,911
KG
41
PKG
***
USD
2021-01-28
13 PALLET CONTAINING 840 C ARTONS PHARMACEUTICALS A S UNDER NAPROXEN TABLETS 500MG 500 S NDC CODE:6846 2019005 FDA PRODUCT CODE N O.:-62 G C A 49 H. T. S NO .:3004.90.92.40 ANDA NO.:- 78-250 THERAPEUTICE USE:-A NTI-INFLAMMATORY,ANALGESIC TOPIRAMATE TABLETS 25MG 60 S NDCCODE:68462010860 FDA PRODUCT CODE NO.:-61 M C A 40 H. T. S NO.:3004.4 9.00.20 ANDA NO.:- 77-627 THERAPEUTICE USE:-ANTICONV ULSANT ZONISAMIDE CAPSULE S 50MG 100 S NDC CODE:6846 2012901 FDA PRODUCT CODE N O.:-61 M C E 44 H. T.S NO .3004.49.00.20 ANDA NO.:-7 7-651 THERAP EUTICE USE:-AN TISEIZURE DRUG 01 DATA LO GGERS HUMIDITY:65% SET TEM PERATURE : +20 DEGREESCO MMERCIAL & CUSTOM INVOICE NO. F2005200374 4 DT. 22.12 .2020 NET WT:2,083.02 F REIGHT PREPAID THE TEMP ERATURE TO BE SET AT +20 D E GREE CELCIUS IN ACCORDANC E WITH SHIPPER INSTRUCTION S ON BEHALF OF : GLENMARK PHARMACEUT ICALS LIMITED N AME ACCOUNT : GLENMARK PHA RMACEUTICALS LIMITED
13 PALLET CONTAINING 840 C ARTONS PHARMACEUTICALS A S UNDER NAPROXEN TABLETS 500MG 500 S NDC CODE:6846 2019005 FDA PRODUCT CODE N O.:-62 G C A 49 H. T. S NO .:3004.90.92.40 ANDA NO.:- 78-250 THERAPEUTICE USE:-A NTI-INFLAMMATORY,ANALGESIC TOPIRAMATE TABLETS 25MG 60 S NDCCODE:68462010860 FDA PRODUCT CODE NO.:-61 M C A 40 H. T. S NO.:3004.4 9.00.20 ANDA NO.:- 77-627 THERAPEUTICE USE:-ANTICONV ULSANT ZONISAMIDE CAPSULE S 50MG 100 S NDC CODE:6846 2012901 FDA PRODUCT CODE N O.:-61 M C E 44 H. T.S NO .3004.49.00.20 ANDA NO.:-7 7-651 THERAP EUTICE USE:-AN TISEIZURE DRUG 01 DATA LO GGERS HUMIDITY:65% SET TEM PERATURE : +20 DEGREESCO MMERCIAL & CUSTOM INVOICE NO. F2005200374 4 DT. 22.12 .2020 NET WT:2,083.02 F REIGHT PREPAID THE TEMP ERATURE TO BE SET AT +20 D E GREE CELCIUS IN ACCORDANC E WITH SHIPPER INSTRUCTION S ON BEHALF OF : GLENMARK PHARMACEUT ICALS LIMITED N AME ACCOUNT : GLENMARK PHA RMACEUTICALS LIMITED
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
2,550
KG
13
PKG
***
USD
2021-03-13
6 PALLET CONTAINING 211 CA RTONS PHARMACEUTICALS AS UNDER NAPROXEN TABLETS 500MG 500 S NDCCODE:68462 019005 FDA PRODUCT CODE NO .:-62 G C A 49 H. T. S NO. : 3004.90.92.40 ANDA NO.:- 78-250 THERAPEUTICE USE:-A NTI-INFLAMMATORY,ANALGESIC NAPROXEN TABLETS 500MG 5 00 S NDCCODE:68462019005 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.:3004.9 0.92.40 ANDA NO.:-78-250 T HERAPEUTICE USE:-ANTI-INFL AMMATORY,ANALGESIC NAPROX EN TABLETS 500MG 500 S NDC CODE:68462019005 FDA PROD UCT CODE NO.:-62 G C A 49 H. T. S NO.:3004.90.92.40 ANDA NO.:-78-250 THERAPEUT ICE USE:-ANTI-INFLAMMATORY ,ANALGESIC DATA LOGGERS H UMIDITY:65% SET TEMPERATUR E : +20 DEGREES COMMERCIA L & CUSTOM INVOI CE NO. F20 052004434 DT. 06.02.2021 F 20052004437 DT. 06.02.2021 F20052004438 DT. 06.02.2021 NET WT:848.520 FREIGH T PREPAID THE TEM PERATU RE TO BE SET AT +20 DEGREE CELCIUS IN ACCORDANCE WIT H SHIPPER INSTRUCTIONS
6 PALLET CONTAINING 211 CA RTONS PHARMACEUTICALS AS UNDER NAPROXEN TABLETS 500MG 500 S NDCCODE:68462 019005 FDA PRODUCT CODE NO .:-62 G C A 49 H. T. S NO. : 3004.90.92.40 ANDA NO.:- 78-250 THERAPEUTICE USE:-A NTI-INFLAMMATORY,ANALGESIC NAPROXEN TABLETS 500MG 5 00 S NDCCODE:68462019005 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.:3004.9 0.92.40 ANDA NO.:-78-250 T HERAPEUTICE USE:-ANTI-INFL AMMATORY,ANALGESIC NAPROX EN TABLETS 500MG 500 S NDC CODE:68462019005 FDA PROD UCT CODE NO.:-62 G C A 49 H. T. S NO.:3004.90.92.40 ANDA NO.:-78-250 THERAPEUT ICE USE:-ANTI-INFLAMMATORY ,ANALGESIC DATA LOGGERS H UMIDITY:65% SET TEMPERATUR E : +20 DEGREES COMMERCIA L & CUSTOM INVOI CE NO. F20 052004434 DT. 06.02.2021 F 20052004437 DT. 06.02.2021 F20052004438 DT. 06.02.2021 NET WT:848.520 FREIGH T PREPAID THE TEM PERATU RE TO BE SET AT +20 DEGREE CELCIUS IN ACCORDANCE WIT H SHIPPER INSTRUCTIONS
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
944
KG
6
PKG
***
USD
2021-02-20
ROCURONIUM BROMIDE INJECTION
ROCURONIUM BROMIDE INJECTION
53313, JAWAHARLAL NEHRU
1601, CHARLESTON, SC
1,067
KG
3
PKG
***
USD
2022-07-02
EMPTY GLASS VIALS OF DIFFERENT SIZESH.S.CODE:INVOICE NO:2001401935DT:6.5.2022S.B.NO:DT:NETWT:934.626 KGS
EMPTY GLASS VIALS OF DIFFERENT SIZESH.S.CODE:INVOICE NO:2001401935DT:6.5.2022S.B.NO:DT:NETWT:934.626 KGS
53313, JAWAHARLAL NEHRU
1001, NEW YORK, NY
1,244
KG
5
PKG
***
USD